CSPC Innovation Pharmaceutical (SHE:300765) on June 18 updated its H-share listing application with the Hong Kong Stock Exchange, according to a Monday filing with the Shenzhen bourse.
The pharmaceutical company initially filed its application on Dec. 10, 2025.
Shares of CSPC Innovation Pharmaceutical rose nearly 1% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments